clear

Independent Thinking Collective Excellence

Briefings

Insights

Space Technology: Back on Earth

Space Technology: Back on Earth

The National Aeronautics and Space Administration (NASA) is at the forefront of technological development for use in space travel and exploration. However, many of the innovations that are developed by, or in collaboration with, NASA are actually used a lot closer to home as well – we take a look at some of NASA’s technologies which have really taken-off here on Earth. Aerogels: outer space to outerwear Traditionally, NASA has used hard aeroshells for delivering payloads, such as rovers, to other planets. These generate drag to slow the payloads in descent, while also acting as heat shields for atmospheric re-entry.  In order to...

Read morekeyboard_arrow_right
A Microbiome of Opportunity

A Microbiome of Opportunity

The human body includes tens of trillions of cells, but not all of them are human! This article focuses on the at-least 30 trillion non-human cells that we each carry with us – our microbiome. These non-human cells include bacterial and fungal species, together with viruses, and can be found throughout our bodies, including the skin, respiratory tract, and gut.  There are many hundreds of species of non-human cell present in varying combinations in different sites throughout the body, with the result that even within one individual there are many incredibly diverse microbiomes. There is also considerable variation between individuals, with...

Read morekeyboard_arrow_right
3D Printing: An Overview

3D Printing: An Overview

With the recent boom in the consumer 3D printing market, it is perhaps easy to forget that early attempts at the technology were made as far back as the 1980s. Indeed, the patent application for the material extrusion technology used in most consumer machines today, namely Fused Deposition Modelling (granted as US 5,121,329), was filed in this period. 3D printing may have started off as a fanciful idea, but it would quickly turn into an effective option for small-scale manufacturing. A breakthrough was made in 1999 when scientists succeeded in printing a human bladder. By 2008, advances in materials science and...

Read morekeyboard_arrow_right
The Startup Patent Dilemma

The Startup Patent Dilemma

“I need a patent to get investment, but I need investment to get a patent!” This is something I hear quite frequently when I meet people involved with very early stage technology businesses, or those with aspirations to start a business.  My first response is usually to commend them on the fact that they are considering an intellectual property (IP) strategy at this point. As many readers will know, patents are time-sensitive. Most jurisdictions, and all the popular ones, now grant patents on a “first-to-file” basis, rather than “first-to-invent”. This means the first one to file a patent application to an invention...

Read morekeyboard_arrow_right
Patents in an Academic Environment

Patents in an Academic Environment

The word “inventor” tends to conjure a picture of an eccentric working late into the night in a garden shed to create weird and wonderful devices. Everything from novelty snowmen to squirrel-proof bird feeders has been patented over the years but most inventions, and inventors, do not in fact fit this stereotype at all. Many inventions arise during the course of in-house commercial research in major industries such as electronics, pharmaceuticals, telecoms or biotechnology and increasingly the academic sector is a major contributor as well. The US Bayh-Dole Act of 1980, which gave US universities control of federally funded inventions that...

Read morekeyboard_arrow_right
Bioinformatics: Revolutionising Healthcare?

Bioinformatics: Revolutionising Healthcare?

You have probably heard talk of bioinformatics - it is an increasingly popular field of research – but do you really know what it is, and how it is affecting research carried out in your area? In short, bioinformatics is about applying statistical and computational techniques to the analysis of biological systems. This is of particular interest in relation to the genome, where a growing number of academics and companies are interested in the applications of genetic analysis in the fields of clinical care, digital health, and personalised medicine. Since the completion of the Human Genome Project in 2003, a number...

Read morekeyboard_arrow_right
Women in STEM: Unsung Heroes of Vaccinology

Women in STEM: Unsung Heroes of Vaccinology

The Covid-19 pandemic has brought STEM out of the lab and into the wider public domain in a way that is relevant to us all. At the start of the pandemic in early 2020, engineers were in a race against the clock to build more mechanical ventilators; mathematical modelling was used to predict how the number of cases could grow; smartphone apps were developed to track the progress of the virus; we clapped for our healthcare professionals; and more recently we have had positive news on the rapid development of a new vaccine. As part of the Ada Lovelace Day...

Read morekeyboard_arrow_right
Understanding IP: Some Common Misconceptions

Understanding IP: Some Common Misconceptions

There is a growing awareness of IP in our society, and the potential value of an IP portfolio is gaining more and more attention. However, misconceptions abound. Let’s debunk five common misunderstandings:  “We have a patent, so we have the right to exploit our invention.” Unfortunately, this is not the case. In fact, IP only provides the right to stop others from doing something - it does not provide the right to do something yourself. Before you exploit your invention, you need to check to see if there are patents owned by third parties that might cover what you plan to...

Read morekeyboard_arrow_right

Looking For Something Specific?

search

Webinars

J A Kemp Webinar: Priority Entitlement in Europe – Current Best Practice

J A Kemp Webinar: The Clinical Trials Dilemma

J A Kemp Webinar: Brexit - The Final Countdown - What will change for Trade Marks and Designs

J A Kemp Webinar: The Microbiome and Claiming Bacteria

J A Kemp Webinar: Strategies for Speeding up or Slowing Down Patent Prosecution

J A Kemp Webinar: Sufficiency at the EPO

J A Kemp Webinar: Dosage Patents in the UK, Europe and Beyond

J A Kemp Webinar: Opposition Practice at the EPO

J A Kemp Webinar: Obtaining Patent Protection for Polymorphs of Drug Compounds

J A Kemp Webinar: Legal Entitlement To Priority – A European Perspective

J A Kemp Webinar: Inventive Step for CII at the EPO

J A Kemp Webinar: Practical Tips On Patent Prosecution In India And China

J A Kemp Webinar: Restoration – Are you taking enough care?

J A Kemp Webinar: Infringement Matters

J A Kemp Webinar: Pregabalin

J A Kemp Webinar: When Patents Go Wrong ... And What To Do About It

J A Kemp Webinar: Is Your Patent Portfolio SPC Ready?

J A Kemp Webinar: Patenting Antibodies at the EPO

J A Kemp Webinar: How to Secure and Exploit Patents for Combination Therapies

Special Topics

Brochures


© 2021 J A Kemp LLP. Regulated by IPReg

keyboard_arrow_up